This is a news story, published by TechSpot, that relates primarily to MIT news.
For more biology news, you can click here:
more biology newsFor more news from TechSpot, you can click here:
more news from TechSpotOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
nanoparticle vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest coronaviruses news, other coronaviruses news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
experimental nanoparticle vaccineTechSpot
•Science
Science
86% Informative
Researchers from MIT and Caltech have developed an experimental nanoparticle vaccine designed to protect against a broad range of coronaviruses.
This includes variants of the virus responsible for Covid-19 and other viruses circulating in animals that could potentially jump to humans in the future.
Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating receptor-binding domains.
VR Score
87
Informative language
88
Neutral language
45
Article tone
informal
Language
English
Language complexity
76
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
3
Source diversity
2
Affiliate links
no affiliate links
Small business owner?
